(BUSINESS WIRE)--Alliqua, Inc. (OTCBB: ALQA) (FWB: HL1) (“Alliqua”), an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health technologies, announced today the appointment of five highly qualified members to its Board of Directors, including: 1) Joseph M. Leone, 2) Michael Goldberg, M.D., 3) Nochum Stein, 4) Kenneth Pearsen, M.D. and 5) Jeffrey Sklar.
